Sovato has announced the successful closure of its Series B funding round to accelerate the development of its pioneering remote robotic surgery (telesurgery) platform. The round was led by venture capital firm Beringea, with participation from Teladoc Health, GS Ventures, and the Laerdal Million Lives Fund, bringing Sovato’s total funding to date to $41 million.

The company plans to use the funds to enhance its technology and forge new strategic partnerships with surgical robotics companies, healthcare providers, and other ecosystem collaborators. Sovato’s system-agnostic platform enables physicians to remotely perform surgical, interventional, and diagnostic procedures using a range of robotic systems.

Although Sovato’s platform has not yet received clearance from the U.S. Food and Drug Administration (FDA), the company has already demonstrated its potential through a successful series of preclinical remote robotic-assisted surgery (RAS) procedures conducted over a 500-mile distance in June 2024.

Cynthia Perazzo, Sovato’s Co-founder and CEO, emphasized the importance of the company’s mission, stating: “Over half the world’s population lacks access to timely, safe surgical care, and in the U.S., millions still travel long distances for routine procedures. This challenge will only intensify as surgeon shortages grow. Remote robotic surgery programs provide a practical solution to extend the reach and impact of skilled surgeons, care teams, and operating rooms, fostering a more sustainable and accessible healthcare model.”

The global robotic surgical systems market is on a strong growth trajectory. According to GlobalData, it is expanding at a compound annual growth rate (CAGR) of 12.1 per cent, expected to rise from $2.9 billion in 2024 to $9.2 billion by 2034.

Sovato’s innovation comes at a critical time as the healthcare industry faces mounting pressure from increasing demand and limited surgical resources. By bridging the gap between advanced surgical technologies and accessibility, Sovato aims to redefine the future of global surgical care.

Germany-based roclub, a company focused on the remote operation of radiological devices such as MRI scanners, also recently raised $11.7 million to support its U.S. expansion—further signaling the growing interest and investment in remote medical technology solutions.